Diabetic Foot Ulcer Treatment Market
Analysts’ Viewpoint
Increase in prevalence of foot ulcers among diabetic patients is one of the key growth factors of the global market. Diabetic foot ulcer treatment market value is projected to increase at a steady pace during the forecast period, owing to the rise in awareness about the availability of effective treatments for the complication among diabetic patients. Growth in demand for advanced wound care devices is further fueling market expansion.
Healthcare professionals are focusing on technological advancements to provide efficient treatment for diabetic foot ulcers that can improve patient outcomes. Key market players are introducing 3D bio-printed scaffolds made using the bio-printing technology, which allows for the precise placement of cells and biomaterials in a three-dimensional structure. Increase in adoption of skin grafting devices is creating lucrative diabetic foot ulcer treatment market opportunities for industry players.
Diabetic foot ulcer is an open sore or wound in the foot that is associated with neuropathic or peripheral artery disease of the lower limb. Diabetes foot ulcers and gangrene are critical diseases, with fatalities equaling cancer deaths.
Diabetic foot infection treatment entails care and management of foot ulcers that occur in patients with diabetes. These ulcers can be challenging to treat and require a collaborative approach from healthcare professionals. The treatment plan consists of wound care, infection control, and glycemic control to promote healing, prevent infection, and minimize the risk of complications.
Diabetic foot ulcer is a common complication of diabetes. It can lead to severe health issues, including infections. Rise in prevalence of diabetes across the globe is contributing to market progress.
Diabetic foot ulceration has a lifetime incidence rate of 19% to 34% and a yearly incidence rate of 2%. Recurrence rate of diabetic foot ulcers after complete healing stands at 40% within a year and 65% within three years. Therefore, demand for effective treatment for diabetic wound infection is estimated to rise across the globe in the near future.
The wound care dressing treatment type segment is projected to account for key share of the global diabetic foot ulcer treatment market during the forecast period. It held significant share in 2022, owing to the availability of a diverse range of wound dressing products and their affordable costs.
Negative Pressure Wound Therapy (NPWT) is an advanced wound care therapy that involves the usage of specialized devices to create a vacuum over the wound. The negative pressure can help promote healing by removing excess fluid, reducing swelling, and stimulating blood flow to the wound bed.
In comparison to ulcers treated with typical gauze dressing, diabetic foot ulcers treated with NPWT benefit from significant reduction in ulcer size, rise in granulation tissue, improvement in pain control, and shorter treatment time.
Based on ulcer type, the global diabetic foot ulcer treatment market has been classified into neuropathic ulcers, ischemic ulcers, and neuro-ischemic ulcers. The neuropathic ulcers segment held the largest share in 2022. The segment is likely to dominate during the forecast period.
The need for neuropathic ulcer treatment is anticipated to rise in the near future, owing to the growth in incidence of diabetic peripheral neuropathy across the globe. Diabetic peripheral neuropathy is the cause of more than 70% to 80% of diabetic foot ulcers. Increase in demand for effective medication for neuropathic ulcers is creating lucrative business opportunities in the diabetic foot ulcer treatment market.
The hospitals end-user segment held significant market share in 2022. It is anticipated to lead the global landscape in the near future.
Hospitals play a critical role in foot ulcer care management by providing specialized diabetic wound treatment and care for patients. Hence, patients with diabetic foot ulcers give priority to hospitals for their treatment.
According to the diabetic foot ulcer treatment market forecast, North America constituted significant share of the global landscape in 2022. The region is estimated to dominate during the forecast period. More than two million Americans suffer from diabetic foot ulcers every year; of these, over 5.0% lose a limb within five years of ulceration.
Countries in North America have enacted supportive government policies for the treatment of diabetic foot ulcers. The National Institute of Health, an agency of the U.S. Department of Health and Human Services, granted US$ 50,000 to Northwell Health for redefining wound care practices for care and welfare of the diabetic population, thus fueling diabetic foot ulcer treatment market growth in the region.
Presence of a favorable regulatory environment and rapid technological advancements in diabetic foot ulcer treatment play a key role in market development in North America.
The diabetic foot ulcer treatment market size in Asia Pacific is projected to increase at a steady pace during the forecast period owing to the presence of advanced healthcare infrastructure, large patient population, and growth in healthcare spending in the region.
According to the International Diabetes Federation, China accounts the largest diabetic population in the world. Consequently, the country has the largest diabetic foot ulcer (DFU) population across the globe. This is augmenting diabetic foot ulcer treatment market demand in Asia Pacific.
Leading market players are focusing on strategies such as new product launches, mergers, partnerships, and collaborations to strengthen their position.
Convatec, Inc., Acelity L.P., Inc., 3M Health Care, Coloplast Corp., Smith & Nephew Plc., B Braun Melsungen AG, Medline Industries, Inc., Organogenesis, Inc., Mölnlycke Health Care, PAUL HARTMANN AG, Centaur Pharmaceuticals, GlaxoSmithKline, Pfizer, and Dr. Reddy’s Laboratories are key players in the global market. These companies are following the latest diabetic foot ulcer treatment market trends to avail lucrative revenue opportunities.
Prominent players have been profiled in the global diabetic foot ulcer treatment market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and latest developments.
| Attribute | Detail |
|---|---|
|
Market Value in 2022 |
US$ 7.0 Bn |
|
Market Forecast Value in 2031 |
More than US$ 11.6 Bn |
|
Growth Rate (CAGR) |
5.8% |
|
Forecast Period |
2023-2031 |
|
Historical Data Available for |
2017-2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
It was valued at US$ 7.0 Bn in 2022
It is projected to reach more than US$ 11.6 Bn by 2031
The CAGR is anticipated to be 5.8% from 2023 to 2031
Increase in prevalence of diabetes, rise in demand for skin grafting procedures, and technological advancements in diabetic foot ulcer treatment
The wound care dressing treatment type segment accounted for major share in 2022
North America is expected to account for major share during the forecast period
Convatec, Inc., Acelity L.P., Inc., 3M Health Care, Coloplast Corp., Smith & Nephew Plc., B Braun Melsungen AG, Medline Industries, Inc., Organogenesis, Inc., Mölnlycke Health Care, PAUL HARTMANN AG, Centaur Pharmaceuticals, GlaxoSmithKline, Pfizer, and Dr. Reddy’s Laboratories
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Diabetic Foot Ulcer Treatment Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Diabetic Foot Ulcer Treatment Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events
5.2. Diabetic Foot Ulcer Prevalence: Overview
5.3. Application of 3D Printing in Treatment of Diabetic Foot Ulcer: Overview
5.4. Technological Advancement in Diabetic Foot Ulcer Management: Overview
5.5. Awareness Programs Assessment
6. Global Diabetic Foot Ulcer Treatment Market Analysis and Forecast, by Treatment Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Treatment Type, 2017-2031
6.3.1. Wound Care Dressing
6.3.1.1. Antimicrobial Dressing
6.3.1.2. Foam Dressing
6.3.1.3. Film Dressing
6.3.1.4. Alginate Dressing
6.3.1.5. Hydrogel Dressing
6.3.1.6. Others
6.3.2. Wound Care Devices
6.3.2.1. Electromagnetic Devices
6.3.2.2. Negative Pressure Wound Therapy (NPWT)
6.3.2.3. Ultra Sound Therapy
6.3.2.4. Hyperbaric Oxygen Therapy (HBOT)
6.3.3. Active Therapies
6.3.3.1. Skin Grafts & Substitutes
6.3.3.2. Growth Factors
6.3.3.3. Hemostatic Agents & Sealants
6.3.4. Antibiotic Medications
6.3.5. Others
6.3.5.1. Pressure Relief Devices
6.3.5.2. Traditional Wound Care Products
6.3.5.3. Others
6.4. Market Attractiveness Analysis, by Treatment Type
7. Global Diabetic Foot Ulcer Treatment Market Analysis and Forecast, by Grade of Ulcer
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Grade of Ulcer, 2017-2031
7.3.1. Grade 1
7.3.2. Grade 2
7.3.3. Grade 3
7.3.4. Grade 4
7.3.5. Grade 5
7.4. Market Attractiveness Analysis, by Grade of Ulcer
8. Global Diabetic Foot Ulcer Treatment Market Analysis and Forecast, by Ulcer Type
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Ulcer Type, 2017-2031
8.3.1. Neuropathic Ulcers
8.3.2. Ischemic Ulcers
8.3.3. Neuro-Ischemic Ulcers
8.4. Market Attractiveness Analysis, by Ulcer Type
9. Global Diabetic Foot Ulcer Treatment Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Specialty Clinics
9.3.4. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Diabetic Foot Ulcer Treatment Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017-2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Diabetic Foot Ulcer Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Treatment Type, 2017-2031
11.2.1. Wound Care Dressing
11.2.1.1. Antimicrobial Dressing
11.2.1.2. Foam Dressing
11.2.1.3. Film Dressing
11.2.1.4. Alginate Dressing
11.2.1.5. Hydrogel Dressing
11.2.1.6. Others
11.2.2. Wound Care Devices
11.2.2.1. Electromagnetic Devices
11.2.2.2. Negative Pressure Wound Therapy (NPWT)
11.2.2.3. Ultra Sound Therapy
11.2.2.4. Hyperbaric Oxygen Therapy (HBOT)
11.2.3. Active Therapies
11.2.3.1. Skin Grafts & Substitutes
11.2.3.2. Growth Factors
11.2.3.3. Hemostatic Agents & Sealants
11.2.4. Antibiotic Medications
11.2.5. Others
11.2.5.1. Pressure Relief Devices
11.2.5.2. Traditional Wound Care Products
11.2.5.3. Others
11.3. Market Value Forecast, by Grade of Ulcer, 2017-2031
11.3.1. Grade 1
11.3.2. Grade 2
11.3.3. Grade 3
11.3.4. Grade 4
11.3.5. Grade 5
11.4. Market Value Forecast, by Ulcer Type, 2017-2031
11.4.1. Neuropathic Ulcers
11.4.2. Ischemic Ulcers
11.4.3. Neuro-Ischemic Ulcers
11.5. Market Value Forecast, by End-user, 2017-2031
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Specialty Clinics
11.5.4. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Treatment Type
11.7.2. By Grade of Ulcer
11.7.3. By Ulcer Type
11.7.4. By End-user
11.7.5. By Country/Sub-region
12. Europe Diabetic Foot Ulcer Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Treatment Type, 2017-2031
12.2.1. Wound Care Dressing
12.2.1.1. Antimicrobial Dressing
12.2.1.2. Foam Dressing
12.2.1.3. Film Dressing
12.2.1.4. Alginate Dressing
12.2.1.5. Hydrogel Dressing
12.2.1.6. Others
12.2.2. Wound Care Devices
12.2.2.1. Electromagnetic Devices
12.2.2.2. Negative Pressure Wound Therapy (NPWT)
12.2.2.3. Ultra Sound Therapy
12.2.2.4. Hyperbaric Oxygen Therapy (HBOT)
12.2.3. Active Therapies
12.2.3.1. Skin Grafts & Substitutes
12.2.3.2. Growth Factors
12.2.3.3. Hemostatic Agents & Sealants
12.2.4. Antibiotic Medications
12.2.5. Others
12.2.5.1. Pressure Relief Devices
12.2.5.2. Traditional Wound Care Products
12.2.5.3. Others
12.3. Market Value Forecast, by Grade of Ulcer, 2017-2031
12.3.1. Grade 1
12.3.2. Grade 2
12.3.3. Grade 3
12.3.4. Grade 4
12.3.5. Grade 5
12.4. Market Value Forecast, by Ulcer Type, 2017-2031
12.4.1. Neuropathic Ulcers
12.4.2. Ischemic Ulcers
12.4.3. Neuro-Ischemic Ulcers
12.5. Market Value Forecast, by End-user, 2017-2031
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Specialty Clinics
12.5.4. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Treatment Type
12.7.2. By Grade of Ulcer
12.7.3. By Ulcer Type
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Diabetic Foot Ulcer Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Treatment Type, 2017-2031
13.2.1. Wound Care Dressing
13.2.1.1. Antimicrobial Dressing
13.2.1.2. Foam Dressing
13.2.1.3. Film Dressing
13.2.1.4. Alginate Dressing
13.2.1.5. Hydrogel Dressing
13.2.1.6. Others
13.2.2. Wound Care Devices
13.2.2.1. Electromagnetic Devices
13.2.2.2. Negative Pressure Wound Therapy (NPWT)
13.2.2.3. Ultra Sound Therapy
13.2.2.4. Hyperbaric Oxygen Therapy (HBOT)
13.2.3. Active Therapies
13.2.3.1. Skin Grafts & Substitutes
13.2.3.2. Growth Factors
13.2.3.3. Hemostatic Agents & Sealants
13.2.4. Antibiotic Medications
13.2.5. Others
13.2.5.1. Pressure Relief Devices
13.2.5.2. Traditional Wound Care Products
13.2.5.3. Others
13.3. Market Value Forecast, by Grade of Ulcer, 2017-2031
13.3.1. Grade 1
13.3.2. Grade 2
13.3.3. Grade 3
13.3.4. Grade 4
13.3.5. Grade 5
13.4. Market Value Forecast, by Ulcer Type, 2017-2031
13.4.1. Neuropathic Ulcers
13.4.2. Ischemic Ulcers
13.4.3. Neuro-Ischemic Ulcers
13.5. Market Value Forecast, by End-user, 2017-2031
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Specialty Clinics
13.5.4. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Treatment Type
13.7.2. By Grade of Ulcer
13.7.3. By Ulcer Type
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Diabetic Foot Ulcer Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Treatment Type, 2017-2031
14.2.1. Wound Care Dressing
14.2.1.1. Antimicrobial Dressing
14.2.1.2. Foam Dressing
14.2.1.3. Film Dressing
14.2.1.4. Alginate Dressing
14.2.1.5. Hydrogel Dressing
14.2.1.6. Others
14.2.2. Wound Care Devices
14.2.2.1. Electromagnetic Devices
14.2.2.2. Negative Pressure Wound Therapy (NPWT)
14.2.2.3. Ultra Sound Therapy
14.2.2.4. Hyperbaric Oxygen Therapy (HBOT)
14.2.3. Active Therapies
14.2.3.1. Skin Grafts & Substitutes
14.2.3.2. Growth Factors
14.2.3.3. Hemostatic Agents & Sealants
14.2.4. Antibiotic Medications
14.2.5. Others
14.2.5.1. Pressure Relief Devices
14.2.5.2. Traditional Wound Care Products
14.2.5.3. Others
14.3. Market Value Forecast, by Grade of Ulcer, 2017-2031
14.3.1. Grade 1
14.3.2. Grade 2
14.3.3. Grade 3
14.3.4. Grade 4
14.3.5. Grade 5
14.4. Market Value Forecast, by Ulcer Type, 2017-2031
14.4.1. Neuropathic Ulcers
14.4.2. Ischemic Ulcers
14.4.3. Neuro-Ischemic Ulcers
14.5. Market Value Forecast, by End-user, 2017-2031
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers
14.5.3. Specialty Clinics
14.5.4. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Treatment Type
14.7.2. By Grade of Ulcer
14.7.3. By Ulcer Type
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Diabetic Foot Ulcer Treatment Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Treatment Type, 2017-2031
15.2.1. Wound Care Dressing
15.2.1.1. Antimicrobial Dressing
15.2.1.2. Foam Dressing
15.2.1.3. Film Dressing
15.2.1.4. Alginate Dressing
15.2.1.5. Hydrogel Dressing
15.2.1.6. Others
15.2.2. Wound Care Devices
15.2.2.1. Electromagnetic Devices
15.2.2.2. Negative Pressure Wound Therapy (NPWT)
15.2.2.3. Ultra Sound Therapy
15.2.2.4. Hyperbaric Oxygen Therapy (HBOT)
15.2.3. Active Therapies
15.2.3.1. Skin Grafts & Substitutes
15.2.3.2. Growth Factors
15.2.3.3. Hemostatic Agents & Sealants
15.2.4. Antibiotic Medications
15.2.5. Others
15.2.5.1. Pressure Relief Devices
15.2.5.2. Traditional Wound Care Products
15.2.5.3. Others
15.3. Market Value Forecast, by Grade of Ulcer, 2017-2031
15.3.1. Grade 1
15.3.2. Grade 2
15.3.3. Grade 3
15.3.4. Grade 4
15.3.5. Grade 5
15.4. Market Value Forecast, by Ulcer Type, 2017-2031
15.4.1. Neuropathic Ulcers
15.4.2. Ischemic Ulcers
15.4.3. Neuro-Ischemic Ulcers
15.5. Market Value Forecast, by End-user, 2017-2031
15.5.1. Hospitals
15.5.2. Ambulatory Surgical Centers
15.5.3. Specialty Clinics
15.5.4. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Treatment Type
15.7.2. By Grade of Ulcer
15.7.3. By Ulcer Type
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Convatec, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Acelity L.P., Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. 3M Health Care
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Coloplast Corp.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Smith & Nephew Plc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. B Braun Melsungen AG
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Medline Industries, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Organogenesis, Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Mölnlycke Health Care
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. PAUL HARTMANN AG
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
16.3.11. Centaur Pharmaceuticals
16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.11.2. Product Portfolio
16.3.11.3. Financial Overview
16.3.11.4. SWOT Analysis
16.3.11.5. Strategic Overview
16.3.12. GlaxoSmithKline
16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.12.2. Product Portfolio
16.3.12.3. Financial Overview
16.3.12.4. SWOT Analysis
16.3.12.5. Strategic Overview
16.3.13. Pfizer
16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.13.2. Product Portfolio
16.3.13.3. Financial Overview
16.3.13.4. SWOT Analysis
16.3.13.5. Strategic Overview
16.3.14. Dr. Reddy’s Laboratories
16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.14.2. Product Portfolio
16.3.14.3. Financial Overview
16.3.14.4. SWOT Analysis
16.3.14.5. Strategic Overview
List of Tables
Table 01: Global Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2031
Table 02: Global Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Wound Care Dressing, 2017-2031
Table 03: Global Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Wound Care Devices, 2017-2031
Table 04: Global Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Active Therapies, 2017-2031
Table 05: Global Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Grade of Ulcer, 2017-2031
Table 06: Global Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Ulcer Type, 2017-2031
Table 07: Global Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 08: Global Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Others, 2017-2031
Table 09: Global Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 10: North America Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 11: North America Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2031
Table 12: North America Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Wound Care Dressing, 2017-2031
Table 13: North America Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Wound Care Devices, 2017-2031
Table 14: North America Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Active Therapies, 2017-2031
Table 15: North America Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Grade of Ulcer, 2017-2031
Table 16: North America Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Ulcer Type, 2017-2031
Table 17: North America Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 18: North America Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Others, 2017‒2031
Table 19: Europe Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 20: Europe Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2031
Table 21: Europe Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Wound Care Dressing, 2017-2031
Table 22: Europe Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Wound Care Devices, 2017-2031
Table 23: Europe Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Active Therapies, 2017-2031
Table 24: Europe Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Grade of Ulcer, 2017-2031
Table 25: Europe Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Ulcer Type, 2017-2031
Table 26: Europe Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 27: Europe Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Others, 2017‒2031
Table 28: Asia Pacific Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 29: Asia Pacific Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2031
Table 30: Asia Pacific Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Wound Care Dressing, 2017-2031
Table 31: Asia Pacific Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Wound Care Devices, 2017-2031
Table 32: Asia Pacific Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Active Therapies, 2017-2031
Table 33: Asia Pacific Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Grade of Ulcer, 2017-2031
Table 34: Asia Pacific Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Ulcer Type, 2017-2031
Table 35: Asia Pacific Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 36: Asia Pacific Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Others 2017‒2031
Table 37: Latin America Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 38: Latin America Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2031
Table 39: Latin America Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Wound Care Dressing, 2017-2031
Table 40: Latin America Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Wound Care Devices, 2017-2031
Table 41: Latin America Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Active Therapies, 2017-2031
Table 42: Latin America Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Grade of Ulcer, 2017-2031
Table 43: Latin America Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Ulcer Type, 2017-2031
Table 44: Latin America Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 45: Latin America Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Others, 2017‒2031
Table 46: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 47: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Treatment Type, 2017-2031
Table 48: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Wound Care Dressing, 2017-2031
Table 49: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Wound Type, 2017-2031
Table 50: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Active Therapies, 2017-2031
Table 51: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Grade of Ulcer, 2017-2031
Table 52: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Ulcer Type, 2017-2031
Table 53: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 54: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, by Others, 2017‒2031
List of Figures
Figure 01: Global Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
Figure 02: Global Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, Treatment Type, 2023-2031
Figure 03: Global Diabetic Foot Ulcer Treatment Market Revenue (US$ Mn), by Wound Care Dressing, 2017-2031
Figure 04: Global Diabetic Foot Ulcer Treatment Market Revenue (US$ Mn), by Wound Care Devices, 2017-2031
Figure 05: Global Diabetic Foot Ulcer Treatment Market Revenue (US$ Mn), by Active Therapies, 2017-2031
Figure 06: Global Diabetic Foot Ulcer Treatment Market Revenue (US$ Mn), by Antibiotic Medications, 2017-2031
Figure 07: Global Diabetic Foot Ulcer Treatment Market Revenue (US$ Mn), by Others, 2017-2031
Figure 08: Global Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Grade of Ulcer, 2022 and 2031
Figure 09: Global Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, by Grade of Ulcer, 2023-2031
Figure 10: Global Diabetic Foot Ulcer Treatment Market Revenue (US$ Mn), by Grade 1, 2017-2031
Figure 11: Global Diabetic Foot Ulcer Treatment Market Revenue (US$ Mn), by Grade 2, 2017-2031
Figure 12: Global Diabetic Foot Ulcer Treatment Market Revenue (US$ Mn), by Grade 3, 2017-2031
Figure 13: Global Diabetic Foot Ulcer Treatment Market Revenue (US$ Mn), by Grade 4, 2017-2031
Figure 14: Global Diabetic Foot Ulcer Treatment Market Revenue (US$ Mn), by Grade 5, 2017-2031
Figure 15: Global Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Ulcer Type, 2022 and 2031
Figure 16: Global Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, Ulcer Type, 2023-2031
Figure 17: Global Diabetic Foot Ulcer Treatment Market Revenue (US$ Mn), by Neuropathic Ulcers, 2017-2031
Figure 18: Global Diabetic Foot Ulcer Treatment Market Revenue (US$ Mn), by Ischemic Ulcers, 2017-2031
Figure 19: Global Diabetic Foot Ulcer Treatment Market Revenue (US$ Mn), by Neuro-Ischemic Ulcers, 2017-2031
Figure 20: Global Diabetic Foot Ulcer Treatment Market Value Share Analysis, by End-user 2022 and 2031
Figure 21: Global Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, End-user, 2023-2031
Figure 22: Global Diabetic Foot Ulcer Treatment Market Revenue (US$ Mn), by Hospitals, 2017-2031
Figure 23: Global Diabetic Foot Ulcer Treatment Market Revenue (US$ Mn), by Ambulatory Surgical Centers, 2017-2031
Figure 24: Global Diabetic Foot Ulcer Treatment Market Revenue (US$ Mn), by Specialty Clinics, 2017-2031
Figure 25: Global Diabetic Foot Ulcer Treatment Market Revenue (US$ Mn), by Others, 2017-2031
Figure 26: Global Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Region, 2022 and 2031
Figure 27: Global Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, by Region, 2023-2031
Figure 28: North America Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, 2017-2031
Figure 29: North America Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 30: North America Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 31: North America Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Treatment Type 2022 and 2031
Figure 32: North America Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, Treatment Type, 2023-2031
Figure 33: North America Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Grade of Ulcer, 2022 and 2031
Figure 34: North America Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, Grade of Ulcer, 2023-2031
Figure 35: North America Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Ulcer Type, 2022 and 2031
Figure 36: North America Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, by Ulcer Type, 2023-2031
Figure 37: North America Diabetic Foot Ulcer Treatment Market Value Share Analysis, by End-user, 2022 and 2031
Figure 38: North America Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, by End-user, 2023-2031
Figure 39: Europe Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, 2017-2031
Figure 40: Europe Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 41: Europe Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 42: Europe Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
Figure 43: Europe Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, Treatment Type, 2023-2031
Figure 44: Europe Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Grade of Ulcer, 2022 and 2031
Figure 45: Europe Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, by Grade of Ulcer, 2023-2031
Figure 46: Europe Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Ulcer Type, 2022 and 2031
Figure 47: Europe Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, by Ulcer Type, 2023-2031
Figure 48: Europe Diabetic Foot Ulcer Treatment Market Value Share Analysis, by End-user, 2022 and 2031
Figure 49: Europe Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, by End-user, 2023-2031
Figure 50: Asia Pacific Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, 2017-2031
Figure 51: Asia Pacific Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 52: Asia Pacific Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 53: Asia Pacific Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Treatment Type2022 and 2031
Figure 54: Asia Pacific Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, Treatment Type, 2023-2031
Figure 55: Asia Pacific Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Grade of Ulcer, 2022 and 2031
Figure 56: Asia Pacific Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, by Grade of Ulcer, 2023-2031
Figure 57: Asia Pacific Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Ulcer Type, 2022 and 2031
Figure 58: Asia Pacific Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, by Ulcer Type, 2023-2031
Figure 59: Asia Pacific Diabetic Foot Ulcer Treatment Market Value Share Analysis, by End-user, 2022 and 2031
Figure 60: Asia Pacific Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, by End-user2023-2031
Figure 61: Latin America Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, 2017-2031
Figure 62: Latin America Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 63: Latin America Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 64: Latin America Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Treatment Type 2022 and 2031
Figure 65: Latin America Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, Treatment Type, 2023-2031
Figure 66: Latin America Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Grade of Ulcer, 2022 and 2031
Figure 67: Latin America Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, Grade of Ulcer, 2023-2031
Figure 68: Latin America Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Ulcer Type, 2022 and 2031
Figure 69: Latin America Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, by Ulcer Type, 2023-2031
Figure 70: Latin America Diabetic Foot Ulcer Treatment Market Value Share Analysis, by End-user, 2022 and 2031
Figure 71: Latin America Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, by End-user, 2023-2031
Figure 72: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value (US$ Mn) Forecast, 2017-2031
Figure 73: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 74: Middle East & Africa Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 75: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Treatment Type, 2022 and 2031
Figure 76: Middle East & Africa Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, Treatment Type, 2023-2031
Figure 77: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Grade of Ulcer, 2022 and 2031
Figure 78: Middle East & Africa Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, Grade of Ulcer, 2023-2031
Figure 79: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value Share Analysis, by Ulcer Type, 2022 and 2031
Figure 80: Middle East & Africa Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, by Ulcer Type, 2023-2031
Figure 81: Middle East & Africa Diabetic Foot Ulcer Treatment Market Value Share Analysis, by End-user, 2022 and 2031
Figure 82: Middle East & Africa Diabetic Foot Ulcer Treatment Market Attractiveness Analysis, by End-user, 2023-2031
Figure 83: Global Diabetic Foot Ulcer Treatment Market Share Analysis, by Company 2022
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes